No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

Published:2012-05-01 Issue:5 Volume:14 Page:468-478
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Tomblyn M.,Chen M.¹,Kukreja M.¹,Aljurf M.D.²,Al Mohareb F.²,Bolwell B.J.³,Cahn J.-Y.⁴,Carabasi M.H.⁵,Gale R.P.⁶,Gress R.E.⁷,Gupta V.⁸,Hale G.A.⁹,Ljungman P.¹⁰,Maziarz R.T.¹¹,Storek J.¹²,Wingard J.R.¹³,Young J.-A.H.¹⁴,Horowitz M.M.¹,Ballen K.K.¹⁵

Affiliation:

1. Center for International Blood and Marrow Transplant Research; Medical College of Wisconsin; Milwaukee; Wisconsin; USA

2. Adult Stem Cell Transplantation; King Faisal Specialist Hospital and Research Center; Riyadh; Saudi Arabia

3. Bone Marrow Transplant; Cleveland Clinic Foundation; Cleveland; Ohio; USA

4. Service d'Hematologie; Hôpital A. Michallon - CHU de Grenoble; Grenoble; France

5. Hematology/Medical Oncology; Thomas Jefferson University Hospital; Philadelphia; Pennsylvania; USA

6. Clinical Research; Celgene Corporation; Summit; New Jersey; USA

7. Experimental Transplantation and Immunology; National Institutes of Health; Bethesda; Maryland; USA

8. Hematology and Medical Oncology; Princess Margaret Hospital; University of Toronto; Toronto; Canada

9. Blood and Marrow Transplant Program; All Children's Hospital; St. Petersburg; Florida; USA

10. Centre for Allogeneic Stem Cell Transplantation; Karolinska University Hospital; Karolinska Institutet; Stockholm; Sweden

11. Bone Marrow Transplant; Center for Hematologic Malignancies; Oregon Health and Science University; Portland; Oregon; USA

12. Bone Marrow Transplant Program; Tom Baker Cancer Centre; University of Calgary; Alberta; Canada

13. Bone Marrow Transplant; Medical Hematology/Oncology; Shands Hospital; University of Florida; Gainesville; Florida; USA

14. Clinical Trials Office; Masonic Cancer Center; University of Minnesota; Minneapolis; Minnesota; USA

15. Bone Marrow Transplant; Massachusetts General Hospital; Boston; Massachusetts; USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3062.2012.00732.x/fullpdf

Reference30 articles.

1. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation;Giaccone;Biol Blood Marrow Transplant,2010

2. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation;Hui;Blood,2005

3. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor;Knoll;J Viral Hepat,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Infections Post Stem Cell Transplant;Basics of Hematopoietic Stem Cell Transplant;2023

2. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Personalized Medicine;2021-10-28

3. Hepatitis B Seropositive Status in Recipients or Donors Is Not Related to Worse Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2021-08

4. Monitoring and management of hepatitis B, C, and HIV infection before and after transplantation;Blood and Marrow Transplantation Long Term Management;2021-03-19

5. Anti‐infective prophylaxis, immunization and prevention of late infectious complications;Blood and Marrow Transplantation Long Term Management;2021-03-19